Bioavailability of Prochlorperazine Suppositories, 25 mg
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare prochlorperazine plasma concentrations produced after
administration of the test formulation with those produced after administration of a marketed
reference product.